Gene rearrangements in malignant lymphomas

Area of Science:

• Hematology
• Oncology
• Molecular Diagnostics

Background:

• Molecular diagnostic methods for malignant lymphoma are established in reference centers.
• Their utility at the community level requires further evaluation.

Purpose of the Study:

• To assess the effectiveness of molecular methods for diagnosing non-Hodgkin's lymphomas (NHL) and lymphoid leukemias (LL) in a community setting.
• To compare molecular techniques with traditional phenotypic analyses.

Main Methods:

• Southern blot methodology was employed.
• Molecular probes targeted immunoglobulin heavy (JH) and light (J kappa) chain joining regions, and T cell receptor beta (J beta 1-2) chain genes.
• Analysis of 57 specimens from patients with NHL, LL, and other lymphoproliferative lesions.

Main Results:

• Gene rearrangements were detected in 90% of all NHL/LL cases, with a 95% detection rate for B-NHL/LL.
• Molecular methods showed higher sensitivity than immunoperoxidase stains (75% B phenotype) and flow cytometry (63% B cell lineage).
• Gene rearrangements were identified in 67% of T-NHL cases; no rearrangements were found in non-lymphoma lesions.

Conclusions:

• Molecular methods provide reliable diagnosis of NHL/LL, even on small specimens.
• These techniques enhance diagnostic confidence and aid in prioritizing specimen handling for optimal information.
• Molecular diagnostics are valuable tools for community-level lymphoma assessment.